Jardiance's CV Benefit: Can A Single Study Carry The Day At FDA?
Agency finds support for cardiovascular mortality benefit with Boehringer/Lilly's diabetes drug, but advisory committee will review weaknesses in outcomes trial's component data.
Agency finds support for cardiovascular mortality benefit with Boehringer/Lilly's diabetes drug, but advisory committee will review weaknesses in outcomes trial's component data.